Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-22-124079)

Filing Details

Accession Number:: 0001104659-22-124079
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-02 16:00:50
Reporting Period:: 2022-12-01

Accepted Time:: 2022-12-02 16:00:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1023024	Ani Pharmaceuticals Inc	ANIP	Pharmaceutical Preparations (2834)	582301143

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1109507	Meridian Venture Partners Ii Lp	259 N. Radnor-Chester Road Suite 130 Radnor PA 19087		No	No	Yes	No
1579672	Jr E. Robert Brown	C/O Biosante Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623		Yes	No	No	No
1580169	Meridian Venture Partners Ii, Co.	259 N. Radnor-Chester Road Suite 130 Radnor PA 19087		No	No	Yes	No
1580170	Meridian Venture Partners Ii Gp, L.p.	259 N. Radnor-Chester Road Suite 130 Radnor PA 19087		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-12-01	200,000	$38.50	2,019,259	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Meridian Venture Partners II, L.P. sold the shares that are the subject of this Form 4 for its liquidity purposes, and no additional sales are planned at this time.